Interpretation of the notice on carrying out the centralized purchase and use of the second batch of drugs organized by the state

Source: National Health Insurance Bureau In order to thoroughly implement the decision-making and deployment of the Party Central Committee and the State Council, maintain the efforts of centralized procurement and use reform, continue to expand the effectiveness of the reform, continue to explore and establish a standardized and normalized centralized procurement and use system of drugs, with the consent of the State Council, the state health insurance bureau and other five departments have formulated the notice on carrying out the second batch of centralized procurement and use of drugs organized by the state（ Hereinafter referred to as "notice"), now the interpretation of "notice" is as follows The state has made steady progress in organizing the pilot project of centralized purchase and use of drugs (hereinafter referred to as the "4 + 7" pilot project) and in expanding the scope of drugs, significantly reducing the burden on the masses, and improving the quality of drugs, with positive results In order to further benefit more patients and form the stable expectation of the society and industry for the reform, the executive meeting of the State Council requested to continue to promote the centralized procurement of drugs and expand the scope of centralized procurement and use of drugs On the basis of summarizing the "4 + 7" pilot and expansion policies and practices, the State Medical Insurance Bureau, the State Health Commission, the State Drug Administration and other departments have formed the second batch of national drug centralized procurement and use ideas In the second batch of national organizations, centralized procurement and use of drugs are still focused on volume procurement Specifically, the procurement alliance is composed of all provinces and Xinjiang production and Construction Corps All public medical institutions and military medical institutions in the alliance area participate in the alliance Medical institutions and retail pharmacies designated by medical insurance designated by social organizations and medical insurance designated by public organizations can participate in the alliance voluntarily After the volume is summarized according to the demand, the procurement with volume will be implemented Continue to insist on the selection of drug varieties from generic drugs corresponding to generic drugs that pass the consistency evaluation of quality and efficacy (including the approval of listing according to the new registration classification of chemical drugs), focus on the selection of more competitive varieties, and consider the clinical efficacy, adverse reactions, batch stability and other factors of drugs The enterprises participating in the centralized purchase must clarify the source and supply guarantee of API The winning enterprise shall guarantee the quality and supply within the purchase agreement period The second batch of countries organized the centralized purchase and use of drugs, on the basis of absorbing the pilot experience, further improved the purchase rules, kept the market moderately competitive, and allowed certain differences in the prices of different selected enterprises of the same drug At the same time, different centralized purchase agreement periods are set according to the number of selected enterprises When the number of selected enterprises is large, the agreement period is relatively long and the market expectation is stable The national unified organization, the provinces and Xinjiang production and Construction Corps form a Procurement Alliance, and entrust the joint procurement office as the centralized procurement platform to organize the implementation Shanghai Pharmaceutical centralized bidding procurement management office is responsible for the daily work of the joint procurement office and the specific implementation.